Planning, securing and defending intellectual property is a challenge which every innovative life science company constantly faces during all stages of the product life cycle.

NeuroScios experts comprehensively analyze segments of the biomedical patent landscape for gaps that could be exploited in accordance with our customers' strategic objectives, conduct freedom-to-operate searches to identify interfering patents, and assist with the drafting of our customers' patent applications.

NeuroScios has accumulated considerable know-how in drug and medical device regulations.

Working at the complex interface between science, business planning, ethics committees, and government authorities, we provide expert strategic advice and can prepare regulatory documents for submissions to the European Medicines Agency and the U.S. Food and Drug Administration.

NeuroScios can plan and handle Scientific Advice procedures at the EMA and the FDA, during which regulators commit themselves to a framework of requirements on which developers can plan the regulatory effort.